Grants > Novel Gene-Therapy Approach for Glaucoma
Updated On: Jul 30, 2025
National Glaucoma Research Grant
Novel Gene-Therapy Approach for Glaucoma
Controlling Eye Pressure in New Ways
About the Research Project
Program
National Glaucoma Research
Award Type
Bold Ideas initiatives
Award Amount
$1,000,000
Active Dates
March 31, 2021 - June 30, 2024
Grant ID
CG2020004
Acknowledgement
Part D of Joint Research Award for a Collaborative Interinstitutional Grant.
Co-Principal Investigator(s)
Goals
The project aims to develop and test resources for Schlemm’s canal specific targeting and expression of genes for gene therapy. Successful development of this targeted therapy will help control eye pressure more effectively and provide better treatment options for glaucoma patients.
Related Grants
National Glaucoma Research
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
National Glaucoma Research
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
Current Organization
Oregon Health & Science University